Deborah Gleeson
drdebgleeson.bsky.social
Deborah Gleeson
@drdebgleeson.bsky.social

Associate Professor in Public Health, La Trobe University; Co-Convener, Political Economy of Health Special Interest Group, PHAA

Economics 32%
Business 32%

My thoughts about Trump's threat to slap tariffs of up to 200% on pharmaceuticals: www.theage.com.au/national/tru...
Trump is toying with us, but his 200% tariff threat could still harm sick Australians
A restriction on the supply of generic medicines to Australia is among genuine risks, regardless of the eventual tariff on pharmaceuticals.
www.theage.com.au

Last week I spoke with Becca Whitehead from MJA Insight about Trump, trade and access to generics in Australia. insightplus.mja.com.au/2025/14/the-...
The PBS targeted in Trump’s trade war: experts fear long term fall out for drug prices and access - InSight+
As the Trump administration continues its program of “reciprocal tariffs” and the pharmaceutical industry calls out the Pharmaceutical Benefits Scheme (PBS) and generic drugs, Australian health expert...
insightplus.mja.com.au

What claims is the Trump Administration making about barriers to trade for its pharmaceutical companies in Australia? Spoiler alert: it's not the PBS, exactly, but the timing of when drug makers find out a generic copy of their product is planning to launch. theconversation.com/trump-has-au...
Trump has Australia’s generic medicines in his sights. And no-one’s talking about it
The major parties say they won’t use the PBS as a bargaining chip in US tariff negotiations. They also need to resist pressure to slow down access to generic drugs.
theconversation.com

I have an exciting PhD scholarship opportunity to share for an interdisciplinary project on 'The Political Economy of the Pharmaceutical Innovation System in the UK and Australia and Access to Medical Products for Pandemics'! More information: www.latrobe.edu.au/study/schola...